anti-Helicobacter pylori, Cag Antigen antibody product blog
Tags: Antibody; Polyclonal Antibody; Helicobacter pylori, Cag Antigen; anti-Helicobacter pylori, Cag Antigen antibody;
The Helicobacter pylori, Cag Antigen n/a (Catalog #MBS617980) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Helicobacter pylori, Cag Antigen can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot.
Dilution: Western Blot: 1:5000 recognizes 100pg of Cag antigen. Researchers should empirically determine the suitability of the Helicobacter pylori, Cag Antigen n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
It is known that H. pylori strains exhibit a significant degree of diversity. The great variability in the H. pylori genome may explain why not all infected individuals suffer from ulcer. Some H. pylori strains contain particular pathogenic genes such as cytokine associated gene A (CagA), while others lack these genes. The CagA protein of H. pylori has been found to be associated with more severe clinical manifestations, such as ulcer disease and gastric cancer. Thus, discrimination between potentially virulent strains may be relevant.
Immunogen: Highly purified Helicobacter pylori, Cag antigen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Helicobacter pylori, Cag Antigen are readily searchable from our website. Different antibodies against the same target such as Helicobacter pylori, Cag Antigen may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.